Megumi Aizawa‐Abe

Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway

Mitsuyo Shintani, Yoshihiro Ogawa, Ken Ebihara et al. · Diabetes · 2001 · 856 citations · Full text

Life Sciences, Endocrinology, Neuroscience +17

Pathophysiological role of leptin in obesity-related hypertension

Megumi Aizawa‐Abe, Yoshihiro Ogawa, Hiroaki Masuzaki et al. · Journal of Clinical Investigation · 2000 · 479 citations · Full text

Life Sciences, Endocrinology, Physiology +13

Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes

Ken Ebihara, Yoshihiro Ogawa, Hiroaki Masuzaki et al. · Diabetes · 2001 · 242 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.

Yoshihiro Ogawa, Hiroaki Masuzaki, Kiminori Hosoda et al. · Diabetes · 1999 · 206 citations

Life Sciences, Endocrinology, Physiology +17

Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.

Ken Ebihara, Yoshihiro Ogawa, Goro Katsuura et al. · Diabetes · 1999 · 175 citations · Full text

Life Sciences, Endocrinology, Physiology +17